In late February 2023 (see NAHC Report), the Drug Enforcement Agency (DEA) proposed a rule intended to govern the prescribing of controlled substances via telemedicine for application at the end of the COVID-19 Public Health Emergency (PHE). The proposed rule focuses on prescribing of a controlled substance via telemedicine consultation by a medical practitioner when no in-person…
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.